VP, Global Portfolio Strategy and Alliance Management

• 2022 - Present

VP Program Management

• 2019 - 2021

Vice President, Program and Alliance Management

• 2016 - 2018

Senior Director, Global Operations Strategy and Business Expansion

• 2014 - 2015

- Tasked by the Executive Strategy Council to lead a $25M business initiative to define and build Cubist’s international infrastructure to support headcount growth and enable global product commercialization; key areas of focus included core financial and HR systems and processes, inventory management, commercial and management reporting, and third party logistics (distribution and order to cash) - Developed and enforced the program structure, governance, and key roles and responsibilities to ensure effective execution and management of a 40+ person team

Director, Program and Portfolio Management

• 2012 - 2014

- Responsible for optimizing the lifecycle value of Cubicin®, an IV antibiotic with over $1B in worldwide sales, focusing on novel formulations and pediatric exclusivity- Led all aspects of planning and management for the option deal to acquire a privately held pharmaceutical company, expediting the internal decision within 2 weeks of data receipt- Led the development of an early stage clinical compound, implementing a translational model to allow for an early decision to discontinue future development- Business lead for company-wide initiative to upgrade Oracle enterprise resource planning (ERP) software. Successfully managed internal and external project teams encompassing core corporate functions resulting in an on time and under budget deliverable

Director, International Alliances

• 2008 - 2012

- Redesigned and launched the global alliance infrastructure, managing key partnerships and supporting early growth of international business resulting in annual revenues of $50M to Cubist- Responsible for the performance planning and management of Cubist’s international business, developing the tools and metrics to maximize the value of the alliances while building Cubist’s reputation as partner of choice - Led commercial interactions with partner in Japan, resulting in the most successful launch of Cubicin® outside of the U.S. through the achievement of the launch year revenue goal - Managed Cubist’s commercial alliance with AstraZeneca for the promotion of Merrem®, generating $20M in annual revenue to Cubist

Sr. Clinical Trials Manager/ Sr. Program Manager

• 2000 - 2007

- Managed clinical study teams responsible for the design and execution of phase 1-3 studies, including a 16 country phase 3 clinical trial leading to the FDA approval of Cubicin® - Designed, implemented and managed the Expanded Access Program and revised the emergency use protocols, allowing patient access to daptomycin prior to product approval - Managed a cross functional team charged with the development and strategic planning for one pre-clinical IND candidate; project discontinued at pre-IND stage due to toxicity issues

Clinical Research Associate

• 1998 - 2000

- Managed all Clinical Operations deliverables including training and oversight of site visits from investigator qualification to close-out - Managed all Clinical Operations deliverables including training and oversight of site visits from investigator qualification to close-out